CYP4F2 and CYP3A5 gene polymorphisms are associated with the reduced risk of non-small cell lung cancer, and its correlation is related to patients’ age and sex and pathological type of lung cancer. This evidence concerns the gene CYP4F2 and non-small cell lung carcinoma.